SB 243213 diHCl is an orally bioavailable, specific and high-affinity 5-hydroxytryptamine (5-HT)2C receptor antagonist with a pKi of 9.37 and a pKb of 9.8 for human 5-HT2C receptor. SB 243213 diHCl has improved anxiolytic profile and has the highly potential for schizophrenia and motor disorders. References: [1]. Wood MD, et al. SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety. Neuropharmacology. 2001 Aug;41(2):186-99.

纯度：≥98%

CAS：1780372-25-9